Calcium hydroxide without nanoparicles

PreclinicalSmall molecule

Calcium hydroxide without nanoparicles is one of 3 small molecule programs targeting Calcium Hydroxide. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Calcium HydroxideCompleted

Calcium HydroxidePreclinical

Completed

Competition

Competitive Landscape

4 competitors in Calcium Hydroxide

#DrugCompanyPhaseTrials

Chitosan

UUniversity Hospital, Basel, Switzerland

Preclinical

1 2

Calcium hydroxide without nanoparicles

PPakistan Institute of Medical Sciences

Preclinical

1 3

Nano Silver Fluoride

OOctober University for Modern Sciences and Arts

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Calcium Hydroxide1 trial

Clinical Efficacy of Novel Jasminum-based Calcium Hydroxide Medicament

Completed·PPakistan Institute of Medical Sciences·N/A·NCT06653608·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Calcium hydroxide without nanoparicles. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Calcium hydroxide without nanoparicles compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Calcium hydroxide without nanoparicles. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pakistan Institute of Medical Sciences company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: PPakistan Institute of Medical Sciences

Calcium hydroxide without nanoparicles

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Calcium Hydroxide1 trial

References

Drug Info

Quick Facts

Related News